Literature DB >> 6407329

The pathology of the feline model of mucopolysaccharidosis I.

M E Haskins, G D Aguirre, P F Jezyk, R J Desnick, D F Patterson.   

Abstract

Five cats with feline alpha-L-iduronidase-deficient mucopolysaccharidosis were studied. Membrane-bound cytoplasmic inclusions were present in central nervous system neurons, hepatocytes, chondrocytes, vascular and splenic smooth muscle cells, bone marrow leukocytes, and fibroblasts of the skin, eye, and cardiac valves. The lesions in these cats closely resemble those described in human patients with mucopolysaccharidosis I H (Hurler syndrome).

Entities:  

Mesh：

Year:  1983        PMID： 6407329      PMCID： PMC1916323     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


  44 in total

1.  Studies on meningiomas in cats.

Authors:  H LUGINBUHL
Journal:  Am J Vet Res       Date:  1961-11       Impact factor: 1.156

2.  Hepatic ultrastructure in the Hurler syndrome.

Authors:  W P Callahan; A E Lorincz
Journal:  Am J Pathol       Date:  1966-02       Impact factor: 4.307

3.  Ultrastructure of cartilage in the Hurler and Sanfilippo syndromes.

Authors:  R Silberberg; D L Rimoin; R E Rosenthal; M B Hasler
Journal:  Arch Pathol       Date:  1972-12

4.  Scheie and Hurler syndromes: apparent identity of the biochemical defect.

Authors:  U Wiesmann; E F Neufeld
Journal:  Science       Date:  1970-07-03       Impact factor: 47.728

5.  Advances in human genetics and impact on society. Conclusion.

Authors:  J F Crow
Journal:  Birth Defects Orig Artic Ser       Date:  1972-07

6.  Genetic heterogeneity and allelic variation in the mucopolysaccharidoses. Introduction.

Authors: 
Journal:  Johns Hopkins Med J       Date:  1980-02

7.  Ocular pathology of the Maroteaux-Lamy syndrome (systemic mucopolysaccharidosis type VI). Histologic and ultrastructural report of two cases.

Authors:  K R Kenyon; T M Topping; W R Green; A E Maumenee
Journal:  Am J Ophthalmol       Date:  1972-05       Impact factor: 5.258

8.  Mucopolysaccharidosis type I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain.

Authors:  A S Dekaban; G Constantopoulos
Journal:  Acta Neuropathol       Date:  1977-07-15       Impact factor: 17.088

9.  Bone cysts in mucopolysaccharidosis I S (Scheie syndrome).

Authors:  J M Lamon; J E Trojak; M A Abbott
Journal:  Johns Hopkins Med J       Date:  1980-02

10.  Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome.

Authors:  P F Jezyk; M E Haskins; D F Patterson; W J Mellman; M Greenstein
Journal:  Science       Date:  1977-11-25       Impact factor: 47.728
View more
  26 in total

1.  Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I.

Authors:  Christian Hinderer; Peter Bell; Brittney L Gurda; Qiang Wang; Jean-Pierre Louboutin; Yanqing Zhu; Jessica Bagel; Patricia O'Donnell; Tracey Sikora; Therese Ruane; Ping Wang; Mark E Haskins; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

2.  Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations.

Authors:  Charles H Vite; Ping Wang; Reema T Patel; Raquel M Walton; Steven U Walkley; Rani S Sellers; N Matthew Ellinwood; Alphonsus S Cheng; Joleen T White; Charles A O'Neill; Mark Haskins
Journal:  Mol Genet Metab       Date:  2011-03-21       Impact factor: 4.797

Review 3.  Gene therapy for lysosomal storage diseases (LSDs) in large animal models.

Authors:  Mark Haskins
Journal:  ILAR J       Date:  2009

Review 4.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

5.  Retarded bone formation in GM1-gangliosidosis: a study of the infantile form and comparison with two canine models.

Authors:  J Alroy; K Knowles; S H Schelling; E M Kaye; A E Rosenberg
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Morphologic and biochemical studies of canine mucopolysaccharidosis I.

Authors:  R M Shull; R G Helman; E Spellacy; G Constantopoulos; R J Munger; E F Neufeld
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

7.  Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities.

Authors:  Susan Wilson; Saadat Hashamiyan; Lorne Clarke; Paul Saftig; John Mort; Valeria M Dejica; Dieter Brömme
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

8.  Bone marrow transplantation for feline mucopolysaccharidosis I.

Authors:  N Matthew Ellinwood; Marie-Anne Colle; Margaret A Weil; Margret L Casal; Charles H Vite; Staci Wiemelt; Christopher W Hasson; Thomas M O'Malley; Xingxuan He; Ulana Prociuk; Lucie Verot; John R Melniczek; Anne Lannon; Gustavo D Aguirre; Van W Knox; Sydney M Evans; Marie T Vanier; Edward H Schuchman; Steven U Walkley; Mark E Haskins
Journal:  Mol Genet Metab       Date:  2007-05-07       Impact factor: 4.797

9.  Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy.

Authors:  Mayra F Garcia-Rivera; Leah E Colvin-Wanshura; Matthew S Nelson; Zhenhong Nan; Shaukat A Khan; Tyson B Rogers; Indrani Maitra; Walter C Low; Pankaj Gupta
Journal:  Brain Res Bull       Date:  2007-08-06       Impact factor: 4.077

Review 10.  Animal models for mucopolysaccharidosis disorders and their clinical relevance.

Authors:  Mark E Haskins
Journal:  Acta Paediatr       Date:  2007-04       Impact factor: 2.299
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.